MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman

by Asabys Partners

Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors And...

Read more

Splice Bio, backed by Ysios Capital, Asabys Partners and Caixa Capital Risc, appoints Jean-Philippe Combal as Chairman of the Board of Directors

by Caixa Capital Risc

Splice Bio, a gene therapy company based on technology developed in the Muir Lab at Princeton University, announced today that it has appointed JeanPhilippe Combal as Chairman of its Board of Director...

Read more

Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys

by Asabys Partners

Nordic digital therapeutics company Sidekick Health has completed a $20 million oversubscribed Series A financing round led by Wellington Partners and Asabys Partners, through its fund SAHII, with par...

Read more

ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio

by Ysios Capital

Splice Bio, a biotech company based on technology developed in the Muir Lab at Princeton University, has announced a new investment into the Company led by Ysios Capital and joined by Asabys Partners ...

Read more

Origo Biopharma raises 2,3M€ in Series Seed financing with the participation from Sabadell Asabys, XesGalicia and the founding shareholders

by Asabys Partners

Origo Biopharma has announced the closing of a €2,3 million Series Seed financing, with the participation from Sabadell Asabys, XesGalicia and the founding shareholders. The financing, led by Sabade...

Read more

Ona Therapeutics raises €30M in Series A financing supported by Alta Life Sciences, Asabys Partners, Bpifrance – InnoBio 2, Fund+ and Ysios Capital

by Asabys Partners

Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today the closing of a €30 million Series A financing, with the par...

Read more

Sabadell Asabys y Alta Life Sciences lideran una ronda en INBRAIN Neuroelectronics. Acuden Finaves, el ICF y otros accionistas ya presentes en la compañía

by Asabys Partners

La ronda ha sido liderada por el fondo Sabadell-Asabys, gestionado por la firma Asabys Partners, y Alta Life Sciences Spain I, a la que se han unido otros inversores como el Institut Català de Financ...

Read more

FOND-ICO Global entra en Sabadell Asabys Health Innovation con 15 millones de euros

by Asabys Partners

Asabys Partners ha anunciado su tercer cierre materializado el pasado 24 de febrero de 2020, en el que se incorpora como inversor principal Fond-ICO Global tras la adjudicación del compromiso de € ...

Read more

ANACONDA BIOMED S.L. secures €20 Million round of funding

by Asabys Partners

Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding will be us...

Read more

Alantra enters venture capital via strategic partnership with Asabys Partners, a VC firm backed by Banc Sabadell

by Alantra

Asabys Partners, a Pan-European Venture Capital firm specialized in investments in the life sciences and health sectors, and Alantra, an investment banking and asset management firm, have reached an a...

Read more

Cara Care Raises $7M Series A Led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Asabys Partners

by Asabys Partners

Digital health company HiDoc Technologies GmbH, dba Cara Care, has announced that it has raised $7 million in Series A funding. The round was led by JJDC and Barcelona-based VC firm Asabys Partners t...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Indexa Capital Group aumenta sus ingreso...

by Indexa Capital

Indexa Capital Group, sociedad matriz de Indexa Capital AV, Bewater As...

Photos Stream